Michael Mark Selected Research

Liraglutide

10/2014	The DPP-IV inhibitor linagliptin and GLP-1 induce synergistic effects on body weight loss and appetite suppression in the diet-induced obese rat.
3/2003	NN-2211 Novo Nordisk.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Michael Mark Research Topics

Disease

12	Type 2 Diabetes Mellitus (MODY) 12/2023 - 03/2003
8	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 05/2024 - 05/2016
5	Neoplasms (Cancer) 05/2024 - 01/2020
5	Body Weight (Weight, Body) 07/2016 - 01/2012
4	Inflammation (Inflammations) 01/2018 - 01/2008
3	Prostatic Neoplasms (Prostate Cancer) 11/2022 - 12/2016
3	Obesity 01/2021 - 01/2012
2	Diabetic Nephropathies (Diabetic Nephropathy) 01/2020 - 01/2020
2	Fibrosis (Cirrhosis) 01/2018 - 09/2014
2	Pneumonia (Pneumonitis) 12/2016 - 09/2012
2	Insulin Resistance 02/2016 - 01/2012
2	Alcoholic Fatty Liver 09/2014 - 07/2010
2	Breast Neoplasms (Breast Cancer) 03/2013 - 09/2012
2	Wounds and Injuries (Trauma) 07/2012 - 06/2005
1	Nausea 05/2024
1	Edema (Dropsy) 05/2024
1	Colitis 02/2024
1	Hepatitis 02/2024
1	Disease Progression 10/2022
1	Lung Neoplasms (Lung Cancer) 10/2022
1	Pain (Aches) 02/2021
1	Chronic Renal Insufficiency 01/2020
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2020
1	Liver Cirrhosis (Hepatic Cirrhosis) 01/2018
1	Adrenal Insufficiency (Adrenal Gland Hypofunction) 12/2016
1	Mesothelioma 12/2016
1	Malignant Mesothelioma 12/2016
1	Heart Failure 07/2016
1	Brain Neoplasms (Brain Tumor) 05/2016
1	Dyslipidemias (Dyslipidemia) 01/2016
1	Neurodegenerative Diseases (Neurodegenerative Disease) 12/2014
1	Weight Loss (Weight Reduction) 10/2014

Drug/Important Bio-Agent (IBA)

14	LinagliptinIBA 12/2023 - 12/2007
10	Dipeptidyl-Peptidase IV InhibitorsIBA 01/2020 - 12/2007
5	Glucose (Dextrose)FDA LinkGeneric 01/2020 - 01/2012
5	Glucagon-Like Peptide 1 (GLP 1)IBA 10/2014 - 03/2003
3	durvalumabIBA 02/2024 - 05/2021
3	Cisplatin (Platino)FDA LinkGeneric 10/2021 - 12/2016
3	Sodium-Glucose Transporter 2 InhibitorsIBA 01/2020 - 01/2016
3	empagliflozinIBA 02/2016 - 01/2014
3	Dipeptidyl-Peptidases and Tripeptidyl-PeptidasesIBA 10/2014 - 04/2008
3	Insulin (Novolin)FDA Link 04/2014 - 03/2003
2	CreatinineIBA 05/2024 - 01/2021
2	Docetaxel (Taxotere)FDA Link 10/2021 - 12/2016
2	Biomarkers (Surrogate Marker)IBA 01/2021 - 01/2018
2	Proteins (Proteins, Gene)FDA Link 01/2021 - 12/2012
2	SodiumIBA 02/2016 - 01/2014
2	Transcription Factors (Transcription Factor)IBA 12/2014 - 09/2014
2	Liraglutide FDA Link 10/2014 - 03/2003
2	Exenatide (Byetta)FDA Link 04/2014 - 01/2012
2	XanthineIBA 07/2013 - 12/2007
2	VildagliptinIBA 02/2009 - 04/2008
2	purineIBA 02/2009 - 04/2008
1	capmatinibIBA 05/2024
1	NivolumabIBA 05/2024
1	Lipase (Acid Lipase)FDA Link 02/2024
1	RNA (Ribonucleic Acid)IBA 10/2022
1	Messenger RNA (mRNA)IBA 10/2022
1	RogaratinibIBA 10/2022
1	Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA 10/2022
1	B7-H1 AntigenIBA 05/2021
1	3-butylidene-4,5-dihydroxyphthalide (BP 42)IBA 02/2021
1	binimetinibIBA 01/2021
1	Pemetrexed (MTA)FDA Link 01/2021
1	AlbuminsIBA 01/2021
1	Mechanistic Target of Rapamycin Complex 1IBA 01/2020
1	Angiotensin Receptor AntagonistsIBA 01/2020
1	KetonesIBA 01/2020
1	lisavanbulinIBA 01/2020
1	Prostate-Specific Antigen (Semenogelase)IBA 01/2019
1	abirateroneIBA 01/2019
1	Metformin (Glucophage)FDA LinkGeneric 01/2019
1	Choline (Choline Chloride)IBA 01/2018
1	Amino Acids FDA Link 01/2018
1	Carbon Tetrachloride (Tetrachloromethane)IBA 01/2018
1	Lysophosphatidic Acid ReceptorsIBA 01/2018
1	Tyrosine Kinase InhibitorsIBA 01/2017
1	PM 01183IBA 12/2016
1	orteronelIBA 12/2016
1	AndrogensIBA 12/2016
1	Uric Acid (Urate)IBA 07/2016
1	Sodium-Glucose Transport ProteinsIBA 07/2016
1	Carboplatin (JM8)FDA LinkGeneric 05/2016
1	Paclitaxel (Taxol)FDA LinkGeneric 05/2016
1	SymportersIBA 02/2016
1	LDL CholesterolIBA 01/2016
1	Dynorphins (Dynorphin)IBA 10/2014
1	Appetite Depressants (Anorectics)IBA 10/2014
1	IncretinsIBA 10/2014
1	Nicotine FDA Link 10/2014

Therapy/Procedure

8	Therapeutics 01/2021 - 07/2010
3	Castration 11/2022 - 12/2016
3	Drug Therapy (Chemotherapy) 10/2021 - 10/2010
2	Oral Administration 01/2018 - 07/2012
2	Glycemic Control 07/2016 - 02/2016
1	Immunotherapy 05/2024
1	Neoadjuvant Therapy 10/2021
1	Cranial Irradiation 01/2020
1	Combined Modality Therapy 12/2016
1	Radiotherapy 12/2016